Acetylsalicylic Acid in Combination with Dihydroergotamine for Preventing Thromboembolism

19826 citationsJournal Article

Authors

M. Schemper · Medical University of Vienna

K Neumann · Medical University of Vienna

Abstract

In a prospective randomized clinical trial involving 150 patients who underwent major abdominal surgery, acetylsalicylic acid (ASA) and dihydroergotamine (DHE) were examined either alone or in combination for their potential to prevent thromboembolism. Combined treatment with ASA and DHE was found to be more effective in preventing the spread of thrombi and their propagation to the femoral veins.

Topics & Keywords

Venous Thromboembolism Diagnosis and Management Antiplatelet Therapy and Cardiovascular Diseases Atrial Fibrillation Management and Outcomes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Pathophysiology of Haemostasis and Thrombosis

Volume 11, Issue 3, pp. 149-153

DOI: 10.1159/000214655

Field-Weighted Citation Impact: 0.00